MedTrace Logo

Contrast Enhanced Ultrasound and Muscle

NCT02128750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-03-07

No results posted yet for this study

Summary

The primary objective of our work is to show that quantification of muscular microvascularisation evaluated by injection of contrast agent is different between chronic critical limb ischemia (before revascularization) and after (healing of ischemia) and thus make the proof of its utility in evaluation of PAD therapeutics.

Conditions

  • Ischemia
  • Thromboangiitis Obliterans

Interventions

OTHER

contrast echographie with hexafluorur of sulfur

Echography of contrast after injection of product of contrast (sonovue (r))

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Christophe Seinturier, Doctor · University Hospital Grenoble - Medecine vasculaire

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128750 on ClinicalTrials.gov